
ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings
Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| 10-Q | 2026-05-07 | English | |
| 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| Major Shareholding Notification 2026 | 2026-04-28 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43600570 | S-8 - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149826 | 10-Q | 2026-05-07 | English | ||
| 43480488 | 8-K - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-05-07 | English | ||
| 46149831 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46149840 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 46149844 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 46149849 | Major Shareholding Notification 2026 | 2026-04-24 | English | ||
| 33051854 | SCHEDULE 13G/A - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Subject) | 2026-03-26 | English | ||
| 46149856 | 8-K | 2026-03-20 | English | ||
| 32882864 | 10-Q - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-02-05 | English | ||
| 24687705 | 8-K Filing | 2026-02-05 | English | ||
| 24687727 | DEF 14A Filing | 2026-01-27 | English | ||
| 32882862 | ARS - ARROWHEAD PHARMACEUTICALS, INC. (0000879407) (Filer) | 2026-01-27 | English | ||
| 46149866 | DEFA14A | 2026-01-26 | English | ||
| 24687718 | 8-K Filing | 2026-01-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Konruns Pharmaceutical Co.,Ltd.
Develops and commercializes innovative surgical hemostasis …
|
603590 | CN | Manufacturing |
|
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.
Develops and manufactures in-vitro diagnostic reagents and …
|
300289 | CN | Manufacturing |
|
Beijing Luzhu Biotechnology Co., Ltd.
R&D and commercialization of innovative human vaccines and …
|
2480 | HK | Manufacturing |
|
Beijing Science Sun Pharmaceutical Co.,LTD.
Develops biochemical medicines for cardiovascular, immune, …
|
300485 | CN | Manufacturing |
|
Beijing SL Pharmaceutical Co., Ltd.
Develops and manufactures drugs for cardiovascular, oncolog…
|
002038 | CN | Manufacturing |
|
Beijing Strong Biotechnologies, Inc
Develops and manufactures IVD products, clinical chemistry …
|
300406 | CN | Manufacturing |
|
Beijing Tiantan Biological Products Corporation Limited
Researches and produces plasma-derived medicinal products a…
|
600161 | CN | Manufacturing |
|
Beijing Tong Ren Tang Chinese Medicine Company Limited
A manufacturer and retailer of traditional Chinese medicine…
|
3613 | HK | Manufacturing |
|
BEIJING TONG REN TANG CO., LTD
Researches, manufactures, and distributes Traditional Chine…
|
600085 | CN | Manufacturing |
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
ARROWHEAD PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31071/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31071 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31071 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31071 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31071}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARROWHEAD PHARMACEUTICALS, INC. (id: 31071)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.